DK176238B1 - In vitro isolering og opretholdelse af embryone stængelceller, (ES)-celler, samt fremgangsmåde til fremstilling af et non-humant kimært dyr - Google Patents

In vitro isolering og opretholdelse af embryone stængelceller, (ES)-celler, samt fremgangsmåde til fremstilling af et non-humant kimært dyr Download PDF

Info

Publication number: DK176238B1
Authority: DK; Denmark
Prior art keywords: cells; lif; culture medium; animal; embryos
Prior art date: 1988-08-04

Application number

DK199100170A

Other languages

Danish (da)

English (en)

Other versions

DK17091D0 (da

DK17091A (da

Inventor

Robert Lindsay Williams

Nicholas Martin Gough

Douglas James Hilton

Original Assignee

Amrad Corp Ltd A Corp Of The S

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-08-04

Filing date

1991-01-31

Publication date

2007-04-10

1991-01-31 Application filed by Amrad Corp Ltd A Corp Of The S filed Critical Amrad Corp Ltd A Corp Of The S

1991-01-31 Publication of DK17091D0 publication Critical patent/DK17091D0/da

1991-04-04 Publication of DK17091A publication Critical patent/DK17091A/da

2007-04-10 Application granted granted Critical

2007-04-10 Publication of DK176238B1 publication Critical patent/DK176238B1/da

Links

241001465754 Metazoa Species 0.000 title claims abstract description 36
210000004027 cell Anatomy 0.000 title claims description 181
238000000034 method Methods 0.000 title claims description 36
238000000338 in vitro Methods 0.000 title claims description 23
210000001671 embryonic stem cell Anatomy 0.000 title claims description 4
238000012423 maintenance Methods 0.000 title abstract description 8
238000002955 isolation Methods 0.000 title description 7
239000001963 growth medium Substances 0.000 claims abstract description 32
210000002257 embryonic structure Anatomy 0.000 claims abstract description 21
238000012258 culturing Methods 0.000 claims abstract description 7
208000032839 leukemia Diseases 0.000 claims abstract description 4
230000002401 inhibitory effect Effects 0.000 claims abstract description 3
108090000581 Leukemia inhibitory factor Proteins 0.000 claims description 82
102000004058 Leukemia inhibitory factor Human genes 0.000 claims description 81
241000699670 Mus sp. Species 0.000 claims description 24
239000002609 medium Substances 0.000 claims description 23
210000002459 blastocyst Anatomy 0.000 claims description 21
235000015097 nutrients Nutrition 0.000 claims description 15
241001529936 Murinae Species 0.000 claims description 14
210000000130 stem cell Anatomy 0.000 claims description 13
241000283690 Bos taurus Species 0.000 claims description 10
241000251468 Actinopterygii Species 0.000 claims description 9
241000271566 Aves Species 0.000 claims description 9
241000283707 Capra Species 0.000 claims description 9
241001494479 Pecora Species 0.000 claims description 9
241000282887 Suidae Species 0.000 claims description 9
230000004048 modification Effects 0.000 claims description 2
238000012986 modification Methods 0.000 claims description 2
238000009795 derivation Methods 0.000 abstract description 2
108090000623 proteins and genes Proteins 0.000 description 13
210000004602 germ cell Anatomy 0.000 description 11
230000027455 binding Effects 0.000 description 10
210000001519 tissue Anatomy 0.000 description 10
101000942967 Homo sapiens Leukemia inhibitory factor Proteins 0.000 description 9
102000046645 human LIF Human genes 0.000 description 9
108091003079 Bovine Serum Albumin Proteins 0.000 description 7
241000287828 Gallus gallus Species 0.000 description 7
235000013330 chicken meat Nutrition 0.000 description 7
239000012894 fetal calf serum Substances 0.000 description 7
241000588724 Escherichia coli Species 0.000 description 6
241000699666 Mus <mouse, genus> Species 0.000 description 6
240000004808 Saccharomyces cerevisiae Species 0.000 description 6
230000000694 effects Effects 0.000 description 6
230000000717 retained effect Effects 0.000 description 6
239000003636 conditioned culture medium Substances 0.000 description 5
238000011161 development Methods 0.000 description 5
230000018109 developmental process Effects 0.000 description 5
230000012010 growth Effects 0.000 description 5
238000002347 injection Methods 0.000 description 5
239000007924 injection Substances 0.000 description 5
230000009261 transgenic effect Effects 0.000 description 5
238000011746 C57BL/6J (JAX™ mouse strain) Methods 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
210000002950 fibroblast Anatomy 0.000 description 4
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
210000001161 mammalian embryo Anatomy 0.000 description 4
101150035614 mbl-1 gene Proteins 0.000 description 4
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 4
206010068051 Chimerism Diseases 0.000 description 3
102100021747 Leukemia inhibitory factor receptor Human genes 0.000 description 3
101710142062 Leukemia inhibitory factor receptor Proteins 0.000 description 3
101000942966 Mus musculus Leukemia inhibitory factor Proteins 0.000 description 3
238000004458 analytical method Methods 0.000 description 3
210000004102 animal cell Anatomy 0.000 description 3
230000005540 biological transmission Effects 0.000 description 3
239000006143 cell culture medium Substances 0.000 description 3
239000011248 coating agent Substances 0.000 description 3
238000000576 coating method Methods 0.000 description 3
238000010494 dissociation reaction Methods 0.000 description 3
230000005593 dissociations Effects 0.000 description 3
238000010166 immunofluorescence Methods 0.000 description 3
208000025113 myeloid leukemia Diseases 0.000 description 3
102000004169 proteins and genes Human genes 0.000 description 3
238000012546 transfer Methods 0.000 description 3
108700028369 Alleles Proteins 0.000 description 2
206010005003 Bladder cancer Diseases 0.000 description 2
102000003951 Erythropoietin Human genes 0.000 description 2
108090000394 Erythropoietin Proteins 0.000 description 2
102000005731 Glucose-6-phosphate isomerase Human genes 0.000 description 2
108010070600 Glucose-6-phosphate isomerase Proteins 0.000 description 2
108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 2
102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 2
102000004877 Insulin Human genes 0.000 description 2
108090001061 Insulin Proteins 0.000 description 2
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 2
102000048143 Insulin-Like Growth Factor II Human genes 0.000 description 2
108090001117 Insulin-Like Growth Factor II Proteins 0.000 description 2
108010002352 Interleukin-1 Proteins 0.000 description 2
229930193140 Neomycin Natural products 0.000 description 2
101710160107 Outer membrane protein A Proteins 0.000 description 2
101710098940 Pro-epidermal growth factor Proteins 0.000 description 2
102000004142 Trypsin Human genes 0.000 description 2
108090000631 Trypsin Proteins 0.000 description 2
108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
238000007792 addition Methods 0.000 description 2
201000001531 bladder carcinoma Diseases 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
239000006285 cell suspension Substances 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
230000000295 complement effect Effects 0.000 description 2
230000001143 conditioned effect Effects 0.000 description 2
230000004069 differentiation Effects 0.000 description 2
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
230000013020 embryo development Effects 0.000 description 2
210000002308 embryonic cell Anatomy 0.000 description 2
229940105423 erythropoietin Drugs 0.000 description 2
DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 2
230000001605 fetal effect Effects 0.000 description 2
229940125396 insulin Drugs 0.000 description 2
210000003734 kidney Anatomy 0.000 description 2
230000007774 longterm Effects 0.000 description 2
210000002894 multi-fate stem cell Anatomy 0.000 description 2
229960004927 neomycin Drugs 0.000 description 2
235000016709 nutrition Nutrition 0.000 description 2
230000037361 pathway Effects 0.000 description 2
239000002953 phosphate buffered saline Substances 0.000 description 2
230000019612 pigmentation Effects 0.000 description 2
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 2
230000009467 reduction Effects 0.000 description 2
230000001177 retroviral effect Effects 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
239000000243 solution Substances 0.000 description 2
210000001082 somatic cell Anatomy 0.000 description 2
230000000392 somatic effect Effects 0.000 description 2
238000012360 testing method Methods 0.000 description 2
239000012588 trypsin Substances 0.000 description 2
208000010570 urinary bladder carcinoma Diseases 0.000 description 2
210000005253 yeast cell Anatomy 0.000 description 2
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
244000291564 Allium cepa Species 0.000 description 1
235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
101000904962 Arabidopsis thaliana Histone H2B.6 Proteins 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
201000009030 Carcinoma Diseases 0.000 description 1
102000016911 Deoxyribonucleases Human genes 0.000 description 1
108010053770 Deoxyribonucleases Proteins 0.000 description 1
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 1
241000490229 Eucephalus Species 0.000 description 1
101150021185 FGF gene Proteins 0.000 description 1
102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
239000007995 HEPES buffer Substances 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
108010002350 Interleukin-2 Proteins 0.000 description 1
108090000978 Interleukin-4 Proteins 0.000 description 1
102000004195 Isomerases Human genes 0.000 description 1
108090000769 Isomerases Proteins 0.000 description 1
206010024305 Leukaemia monocytic Diseases 0.000 description 1
102100032352 Leukemia inhibitory factor Human genes 0.000 description 1
241000699660 Mus musculus Species 0.000 description 1
238000011887 Necropsy Methods 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
102000016941 Rho Guanine Nucleotide Exchange Factors Human genes 0.000 description 1
108010053823 Rho Guanine Nucleotide Exchange Factors Proteins 0.000 description 1
102000001332 SRC Human genes 0.000 description 1
108060006706 SRC Proteins 0.000 description 1
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
208000036142 Viral infection Diseases 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000002776 aggregation Effects 0.000 description 1
238000004220 aggregation Methods 0.000 description 1
238000013459 approach Methods 0.000 description 1
238000000376 autoradiography Methods 0.000 description 1
230000008901 benefit Effects 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
210000001109 blastomere Anatomy 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
239000002771 cell marker Substances 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
230000008859 change Effects 0.000 description 1
230000001427 coherent effect Effects 0.000 description 1
238000001816 cooling Methods 0.000 description 1
208000031513 cyst Diseases 0.000 description 1
238000009826 distribution Methods 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
230000004720 fertilization Effects 0.000 description 1
230000013595 glycosylation Effects 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
210000002149 gonad Anatomy 0.000 description 1
238000011534 incubation Methods 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000010354 integration Effects 0.000 description 1
230000003993 interaction Effects 0.000 description 1
238000002372 labelling Methods 0.000 description 1
238000001499 laser induced fluorescence spectroscopy Methods 0.000 description 1
230000003902 lesion Effects 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
238000013507 mapping Methods 0.000 description 1
239000003550 marker Substances 0.000 description 1
230000013011 mating Effects 0.000 description 1
201000006894 monocytic leukemia Diseases 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
210000000066 myeloid cell Anatomy 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
RLZZZVKAURTHCP-UHFFFAOYSA-N phenanthrene-3,4-diol Chemical compound C1=CC=C2C3=C(O)C(O)=CC=C3C=CC2=C1 RLZZZVKAURTHCP-UHFFFAOYSA-N 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
230000000644 propagated effect Effects 0.000 description 1
230000001902 propagating effect Effects 0.000 description 1
238000011002 quantification Methods 0.000 description 1
210000003079 salivary gland Anatomy 0.000 description 1
238000013391 scatchard analysis Methods 0.000 description 1
238000013390 scatchard method Methods 0.000 description 1
229910052709 silver Inorganic materials 0.000 description 1
239000004332 silver Substances 0.000 description 1
230000009870 specific binding Effects 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
108700026239 src Genes Proteins 0.000 description 1
238000010186 staining Methods 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
210000001541 thymus gland Anatomy 0.000 description 1
238000011830 transgenic mouse model Methods 0.000 description 1
210000000143 trophectoderm cell Anatomy 0.000 description 1
125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
230000009385 viral infection Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/235—Leukemia inhibitory factor [LIF]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Environmental Sciences (AREA)
Developmental Biology & Embryology (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Animal Behavior & Ethology (AREA)
Cell Biology (AREA)
Microbiology (AREA)
Biodiversity & Conservation Biology (AREA)
Animal Husbandry (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK199100170A 1988-08-04 1991-01-31 In vitro isolering og opretholdelse af embryone stængelceller, (ES)-celler, samt fremgangsmåde til fremstilling af et non-humant kimært dyr DK176238B1 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
AUPI964488		1988-08-04
AUPI964488		1988-08-04
AU8900330		1989-08-03
PCT/AU1989/000330 WO1990001541A1 (en)	1988-08-04	1989-08-03	In vitro propagation of embryonic stem cells

Publications (3)

Publication Number	Publication Date
DK17091D0 DK17091D0 (da)	1991-01-31
DK17091A DK17091A (da)	1991-04-04
DK176238B1 true DK176238B1 (da)	2007-04-10

Family

ID=3773256

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK199100170A DK176238B1 (da)	1988-08-04	1991-01-31	In vitro isolering og opretholdelse af embryone stængelceller, (ES)-celler, samt fremgangsmåde til fremstilling af et non-humant kimært dyr

Country Status (10)

Country	Link
US (1)	US5166065A (de)
EP (1)	EP0380646B1 (de)
JP (1)	JP2740320B2 (de)
AT (1)	ATE175994T1 (de)
AU (1)	AU623922B2 (de)
CA (1)	CA1341469C (de)
DE (1)	DE68928914T2 (de)
DK (1)	DK176238B1 (de)
NO (1)	NO322243B1 (de)
WO (1)	WO1990001541A1 (de)

Families Citing this family (99)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030032178A1 (en) *	1988-08-04	2003-02-13	Williams Robert Lindsay	In vitro propagation of embryonic stem cells
AU622515B2 (en) *	1989-01-10	1992-04-09	Amrad Operations Pty. Limited	Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells
DE69028514T2 (de) *	1989-01-10	1997-02-20	Amrad Corp Ltd	Leukämiehemmender faktor aus vieharten und seine verwendung zur verbesserung der implantation und der entwicklung von embryonalen zellen
US5705732A (en) *	1989-06-12	1998-01-06	Oklahoma Medical Research Foundation	Universal donor cells
JP3040815B2 (ja) *	1989-11-24	2000-05-15	モナッシュ・ユニバーシティ	随伴細胞に及ぼす白血病抑制因子の増殖作用
JP3049091B2 (ja) *	1990-03-20	2000-06-05	アムラド・コーポレイション・リミテッド	ニューロン増殖及び維持を調節する方法
WO1992001040A1 (en) *	1990-07-09	1992-01-23	Amrad Corporation Limited	Enhanced implantation, development and maintenance of embryos using leukaemia inhibitory factor
ES2237747T3 (es) *	1991-11-14	2005-08-01	Prionics Ag	Animales transgenicos no humanos que carecen de proteinas prionicas.
US5453357A (en) *	1992-10-08	1995-09-26	Vanderbilt University	Pluripotential embryonic stem cells and methods of making same
US7153684B1 (en)	1992-10-08	2006-12-26	Vanderbilt University	Pluripotential embryonic stem cells and methods of making same
US5690926A (en) *	1992-10-08	1997-11-25	Vanderbilt University	Pluripotential embryonic cells and methods of making same
GB9308271D0 (en) *	1993-04-21	1993-06-02	Univ Edinburgh	Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
US5523226A (en) *	1993-05-14	1996-06-04	Biotechnology Research And Development Corp.	Transgenic swine compositions and methods
WO1995006716A1 (en) *	1993-08-30	1995-03-09	Northwestern University	Rat pluripotent embryonic stem cells and method of obtaining and using same
US6686198B1 (en) *	1993-10-14	2004-02-03	President And Fellows Of Harvard College	Method of inducing and maintaining neuronal cells
DE69434934D1 (de) *	1993-10-14	2007-04-12	Harvard College	Verfahren zur induzierung und zur erhaltung neuronalen zellen
US6432711B1 (en) *	1993-11-03	2002-08-13	Diacrin, Inc.	Embryonic stem cells capable of differentiating into desired cell lines
GB9401380D0 (en) *	1994-01-25	1994-03-23	Pharmaceutical Proteins Ltd	Embryonic cell isolation
FR2726003B1 (fr) *	1994-10-21	2002-10-18	Agronomique Inst Nat Rech	Milieu de culture de cellules embryonnaires totipotentes aviaires, procede de culture de ces cellules, et cellules embryonnaires totipotentes aviaires
US5874301A (en) *	1994-11-21	1999-02-23	National Jewish Center For Immunology And Respiratory Medicine	Embryonic cell populations and methods to isolate such populations
US5843780A (en)	1995-01-20	1998-12-01	Wisconsin Alumni Research Foundation	Primate embryonic stem cells
US5728581A (en) *	1995-06-07	1998-03-17	Systemix, Inc.	Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein
CA2242666A1 (en)	1996-01-09	1997-07-17	The Regents Of The University Of California	Ungulate embryonic stem-like cells, methods of making and using the cells to produce transgenic ungulates
AU4353696A (en)	1996-01-09	1997-08-01	Regents Of The University Of California, The	Ungulate embryonic stem-like cells, making and using the cells to produce transgenic ungulate
US6247995B1 (en)	1996-02-06	2001-06-19	Bruce Bryan	Bioluminescent novelty items
US5876995A (en)	1996-02-06	1999-03-02	Bryan; Bruce	Bioluminescent novelty items
AU2192997A (en) *	1996-02-28	1997-09-16	Vanderbilt University	Compositions and methods of making embryonic stem cells
CN1217746A (zh) *	1996-04-29	1999-05-26	勒芬研究与发展公司	多能性兔胚胎干(es)细胞系及其在嵌合兔的产生中的应用
US7544511B2 (en) *	1996-09-25	2009-06-09	Neuralstem Biopharmaceuticals Ltd.	Stable neural stem cell line methods
AU3392697A (en) *	1996-06-14	1998-01-07	Regents Of The University Of California, The	(in vitro) derivation and culture of primate pluripotent stem cells and therapeutic uses thereof
US6416960B1 (en)	1996-08-08	2002-07-09	Prolume, Ltd.	Detection and visualization of neoplastic tissues and other tissues
EP1015872B1 (de)	1996-12-12	2005-03-02	Prolume, Ltd.	Vorrichtung und verfahren zum nachweis und identifizieren von infektiösen wirkstoffen
US6011197A (en)	1997-03-06	2000-01-04	Infigen, Inc.	Method of cloning bovines using reprogrammed non-embryonic bovine cells
NZ337495A (en) *	1997-03-06	2001-06-29	Infigen Inc	Bovine primordial germ cells and their use in cloning
US6090622A (en) *	1997-03-31	2000-07-18	The Johns Hopkins School Of Medicine	Human embryonic pluripotent germ cells
US6331406B1 (en)	1997-03-31	2001-12-18	The John Hopkins University School Of Medicine	Human enbryonic germ cell and methods of use
AU729377B2 (en)	1997-10-23	2001-02-01	Asterias Biotherapeutics, Inc.	Methods and materials for the growth of primate-derived primordial stem cells in feeder-free culture
US6027937A (en) *	1998-08-18	2000-02-22	Harper; William	Method for propagation of insecta germ cells
US6767737B1 (en) *	1998-08-31	2004-07-27	New York University	Stem cells bearing an FGF receptor on the cell surface
US6667176B1 (en) *	2000-01-11	2003-12-23	Geron Corporation	cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
US7410798B2 (en) *	2001-01-10	2008-08-12	Geron Corporation	Culture system for rapid expansion of human embryonic stem cells
US20020168766A1 (en) *	2000-01-11	2002-11-14	Gold Joseph D.	Genetically altered human pluripotent stem cells
ATE408667T1 (de) *	1999-07-20	2008-10-15	Univ Southern California	Identifizierung pluripotenter prämesenchymaler, prähämotopoietischer vorläuferzellen
US6333192B1 (en) *	1999-08-09	2001-12-25	North Carolina State University	Method of producing an undifferentiated avian cell culture using avian primordial germ cells
US7455983B2 (en) *	2000-01-11	2008-11-25	Geron Corporation	Medium for growing human embryonic stem cells
US6828145B2 (en)	2000-05-10	2004-12-07	Cedars-Sinai Medical Center	Method for the isolation of stem cells by immuno-labeling with HLA/MHC gene product marker
WO2001091548A2 (en) *	2000-06-01	2001-12-06	Pharmacia & Upjohn Company	Mice heterozygous for wfs1 gene as mouse models for depression
KR100865664B1 (ko) *	2000-06-14	2008-10-29	비스타겐 인코포레이티드	간 줄기 세포를 사용하는 독성 타이핑
EA013564B1 (ru) *	2000-08-03	2010-06-30	Терапеутик Хьюман Поликлоналз Инк.	Гуманизированный иммуноглобулин и содержащая его фармацевтическая композиция
ATE466089T1 (de)	2000-12-22	2010-05-15	Agronomique Inst Nat Rech	Positionsunabhängige und gewebespezifische expression eines transgens in der milch eines transgen-tieres
CA2435826A1 (en) *	2001-01-24	2002-08-01	The Government Of The United States Of America	Differentiation of stem cells to pancreatic endocrine cells
US20030211605A1 (en) *	2001-05-01	2003-11-13	Lee Sang-Hun	Derivation of midbrain dopaminergic neurons from embryonic stem cells
US7129034B2 (en) *	2001-10-25	2006-10-31	Cedars-Sinai Medical Center	Differentiation of whole bone marrow
US6759244B2 (en)	2001-11-08	2004-07-06	Art Institute Of New York And New Jersey, Inc.	Composite blastocysts (CBs) from aggregates of dissociated cells of non-viable pre-embryos
GB0220145D0 (en) *	2002-08-30	2002-10-09	Thromb X Nv	Novel compositions for the in vitro derivation and culture of embryonic stem (ES) cell lines with germline transmission capability
WO2003054169A1 (en) *	2001-12-21	2003-07-03	Thromb-X Nv	Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability
JP4408371B2 (ja) *	2001-12-21	2010-02-03	トロンボジェニクス・ナムローゼ・フエンノートシャップ	生殖細胞系伝達能力を有する胚性幹（ｅｓ）細胞のインビトロの誘導および培養のための組成物
US7145057B2 (en)	2002-02-01	2006-12-05	Origen Therapeutics, Inc.	Chimeric bird from embryonic stem cells
FR2836924B1 (fr)	2002-03-08	2005-01-14	Vivalis	Lignees de cellules aviaires utiles pour la production de substances d'interet
US20030207448A1 (en) *	2002-05-06	2003-11-06	Revera Gregory Henry	Methodologies for the creation of pluripotent or multipotent human stem cells without creating or destroying a human embryo
CA2504179A1 (en) *	2002-10-31	2004-05-13	Riken	Composition for culturing multipotent stem cells and utilization of the same
US8293488B2 (en)	2002-12-09	2012-10-23	Neuralstem, Inc.	Method for screening neurogenic agents
AU2003293409A1 (en) *	2002-12-09	2004-06-30	Karl K. Johe	Method for discovering neurogenic agents
ES2705683T3 (es) *	2002-12-16	2019-03-26	Technion Res & Dev Foundation	Medio de cultivo de células madre pluripotentes
US20040191839A1 (en) *	2003-03-28	2004-09-30	National Institute Of Agrobiological Sciences Japan	Methods for sorting undifferentiated cells and uses thereof
IL155783A (en)	2003-05-05	2010-11-30	Technion Res & Dev Foundation	Multicellular systems of pluripotent human embryonic stem cells and cancer cells and uses thereof
WO2006040615A2 (en) *	2003-06-11	2006-04-20	Jan Remmereit	Differenciation of stem cells for therapeutic use
CA2569978C (en) *	2004-06-09	2017-06-06	The University Court Of The University Of Edinburgh	Neural stem cells
US20050277124A1 (en) *	2004-06-10	2005-12-15	White Steven M	Cardiac conduction system cells and uses thereof
WO2005123900A1 (en) *	2004-06-10	2005-12-29	Merial Limited	Medium and methods for culturing of avian primordial germ cells
WO2006023422A2 (en) *	2004-08-16	2006-03-02	Kouns George S	Stem-like cells
CN101084303A (zh) *	2004-11-17	2007-12-05	神经干公司	用于治疗神经变性症状的人类神经细胞的移植
CN1298843C (zh) *	2005-02-07	2007-02-07	十堰市太和医院	不依赖饲养细胞的人胚干细胞培养基
KR20160116024A (ko) *	2005-06-22	2016-10-06	아스테리아스 바이오세라퓨틱스, 인크.	인간 배아 줄기 세포의 현탁 배양
EP2422802A3 (de)	2006-03-07	2013-03-06	Geeta Shroff	Zusammentsetzungen enhaltend menschliche embryonale Stammzellen und ihre Derivate, Verwendung davon und Verfahren zur ihrer Vorbereitung
AU2007285483B2 (en)	2006-05-11	2011-12-22	Regenics As	Administration of cells and cellular extracts for rejuvenation
US20080003676A1 (en) *	2006-06-26	2008-01-03	Millipore Corporation	Growth of embryonic stem cells
EP2500417A1 (de)	2006-08-09	2012-09-19	Vivalis	Verfahren zur Herstellung von transgenen Vögeln unter Verwendung von embryonalen Stammzellen
ATE536374T1 (de)	2006-09-01	2011-12-15	Therapeutic Human Polyclonals Inc	Erhöhte expression von humanem oder humanisiertem immunglobulin bei nicht-humanen transgenen tieren
US8685720B2 (en)	2006-11-03	2014-04-01	The Trustees Of Princeton University	Engineered cellular pathways for programmed autoregulation of differentiation
US20080206864A1 (en) *	2006-11-22	2008-08-28	Derrick Rancourt	Methods and Materials for Culturing Murine Embryonic Stem Cells
US20080267874A1 (en) *	2007-03-28	2008-10-30	The Buck Institute For Age Research	Targeted Neuronal And Glial Human Embryonic Stem Cell Line
EP1985305A1 (de)	2007-04-24	2008-10-29	Vivalis	Aus Entenembryonen gewonnene Stammzellkulturen zur Herstellung von Impfstoffen gegen Viren
CA2723848C (en)	2008-05-09	2013-01-08	Regenics As	Method of making salmon egg cytoplasmic extracts and use for increasing collagen production in skin
US20100158878A1 (en)	2008-12-23	2010-06-24	Alexandra Capela	Target populations of oligodendrocyte precursor cells and methods of making and using same
US8642334B2 (en)	2009-02-17	2014-02-04	Memorial Sloan Kettering Cancer Center	Methods of neural conversion of human embryonic stem cells
CN101962630B (zh) *	2009-07-23	2013-04-10	北京大学	诱导人胚胎干细胞或人诱导形成的多潜能干细胞向肝细胞分化的方法
AU2011249478B2 (en)	2010-05-06	2014-12-04	Regenics As	Use of cellular extracts for skin rejuvenation
CN103237553A (zh)	2010-07-28	2013-08-07	神经干细胞公司	治疗和/或逆转神经退行性疾病和/或病症的方法
PT2773748T (pt)	2011-11-04	2020-03-26	Memorial Sloan Kettering Cancer Center	Neurónios dopaminérgicos (da) do mesencéfalo para enxerto
EP3459522B1 (de)	2012-12-10	2021-02-17	Regenics AS	Verwendung von zellextrakten zur wundbehandlung
EP3498824A1 (de)	2013-04-26	2019-06-19	Memorial Sloan-Kettering Cancer Center	Durch gezielte differenzierung pluripotenter und multipotenter zellen hergestellte kortikale interneuronen und andere neuronale zellen
JP6723918B2 (ja)	2013-11-21	2020-07-15	メモリアルスローンケタリングキャンサーセンター	ヒト多能性幹細胞からの機能的頭蓋プラコード派生体の特定
EP3194623B1 (de)	2014-08-12	2022-01-05	Wayne State University	Systeme und verfahren zur erkennung von stress von stammzellen und verwendungen davon
MX382488B (es)	2014-10-20	2025-03-13	Neuralstem Inc	Celulas madre neurales estables que comprenden un polinucleótido exógeno que codifica un factor de crecimiento y métodos de uso de las mismas.
CN109689089A (zh)	2016-05-25	2019-04-26	国家医疗保健研究所	治疗癌症的方法和组合物
KR20250008153A (ko)	2017-11-24	2025-01-14	인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔)	암 치료를 위한 방법 및 조성물
WO2020030634A1 (en)	2018-08-06	2020-02-13	INSERM (Institut National de la Santé et de la Recherche Médicale)	Methods and compositions for treating cancers
EP4314246A1 (de)	2021-04-01	2024-02-07	INSERM (Institut National de la Santé et de la Recherche Médicale)	Verfahren zur herstellung von leberorganoiden, damit erhaltene leberorganoide und verwendungen davon

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT87133B (pt) *	1987-04-02	1992-07-31	Amrad Corp Ltd	Metodo de purificacao do factor inibidor da leucemia (lif) e de composicoes farmaceuticas contendo polipeptidos com actividade do lif

1989
- 1989-08-03 JP JP1508674A patent/JP2740320B2/ja not_active Expired - Lifetime
- 1989-08-03 DE DE68928914T patent/DE68928914T2/de not_active Expired - Lifetime
- 1989-08-03 CA CA000607433A patent/CA1341469C/en not_active Expired - Lifetime
- 1989-08-03 AT AT89909126T patent/ATE175994T1/de not_active IP Right Cessation
- 1989-08-03 US US07/477,960 patent/US5166065A/en not_active Expired - Lifetime
- 1989-08-03 EP EP89909126A patent/EP0380646B1/de not_active Expired - Lifetime
- 1989-08-03 AU AU40590/89A patent/AU623922B2/en not_active Expired
- 1989-08-03 WO PCT/AU1989/000330 patent/WO1990001541A1/en not_active Ceased
1991
- 1991-01-31 DK DK199100170A patent/DK176238B1/da not_active IP Right Cessation
- 1991-02-01 NO NO19910385A patent/NO322243B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
DK17091D0 (da)	1991-01-31
JPH03503241A (ja)	1991-07-25
DE68928914D1 (de)	1999-03-04
JP2740320B2 (ja)	1998-04-15
HK1003208A1 (en)	1998-10-16
NO322243B1 (no)	2006-09-04
AU623922B2 (en)	1992-05-28
CA1341469C (en)	2004-12-28
NO910385L (no)	1991-04-04
EP0380646A4 (en)	1991-01-23
DK17091A (da)	1991-04-04
US5166065A (en)	1992-11-24
AU4059089A (en)	1990-03-05
ATE175994T1 (de)	1999-02-15
DE68928914T2 (de)	1999-09-09
WO1990001541A1 (en)	1990-02-22
NO910385D0 (no)	1991-02-01
EP0380646B1 (de)	1999-01-20
EP0380646A1 (de)	1990-08-08

Legal Events

Date	Code	Title	Description
2009-08-24	PUP	Patent expired

Publication	Publication Date	Title
DK176238B1 (da)	2007-04-10	In vitro isolering og opretholdelse af embryone stængelceller, (ES)-celler, samt fremgangsmåde til fremstilling af et non-humant kimært dyr
US7186883B2 (en)	2007-03-06	In vitro propagation of embryonic stem cells
US6500668B2 (en)	2002-12-31	Culture medium for avian embryonic cells
Park et al.	2003	Birth of germline chimeras by transfer of chicken embryonic germ (EG) cells into recipient embryos
US9434922B2 (en)	2016-09-06	Feeder-free method for culture of bovine and porcine spermatogonial stem cells
US6156569A (en)	2000-12-05	Prolonged culturing of avian primordial germ cells (PGCs) using specific growth factors, use thereof to produce chimeric avians
DE69832716T2 (de)	2006-09-14	Herstellung embryonischer vogel keimzellinien durch verlängerte kultivierung von pgcs, verwendung desselben zur klonierung und chimerisierung
CN1195844C (zh)	2005-04-06	鸟原始生殖细胞(pgc)细胞系及其长期培养的方法
WO1994007997A1 (en)	1994-04-14	Long-term proliferation of primordial germ cells
US7476776B2 (en)	2009-01-13	Method for improving germline transmission efficiency of avian primordial germ cells
AU2015225014A1 (en)	2015-10-01	Feeder-free method for culture of bovine and porcine spermatogonial stem cells
HK1003208B (en)	2000-03-24	Use of leukaemia inhibitory factor (lif) for the (in vitro) propagation of embryonic stem cells
WO2000008132A1 (en)	2000-02-17	Prolonged culturing of avian primordial germ cells using specific growth factors and use thereof
Piedrahita	1989	Studies on the isolation of embryonic stem (ES) cells: Comparative behavior of murine, porcine, and ovine species
Larsen	1996	Is there an Embryological Basis for the Association of Mediastinal Germ Cell Tumors and Hematologic Cancers? A Review
Larsen	2012	IS THERE AN EMBRYOLOGICAL BASIS FOR THE ASSOCIATION OF MEDIASTINAL GERM CELL TUMORS AND HEMATOLOGIC CANCERS?
Lee et al.	2006	Study on germline transmission by transplantation of spermatogonial stem cells in chicken
MXPA00001301A (en)	2001-11-21	Avian primordial germ cell (pgc) cell line and a method for long term culturing thereof